Heart monitoring study for esophageal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study tests a non-invasive heart monitor (seismocardiography) to see if it can predict how well patients recover after esophageal cancer surgery. The goal is to improve surgical planning and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have esophageal or gastro-esophageal junction adenocarcinoma (not squamous cell carcinoma).
- You are scheduled for chemotherapy followed by surgery (esophagectomy or esophago-gastrectomy).
- You are able to give informed consent.
- You do not have a pacemaker or implantable defibrillator.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a home-based program using mobile health technology to help prepare patients with stomach or gastroesophageal junction cancer for surgery. The goal is to improve recovery before and after surgery through exercise, nutrition, and psychological support.
This trial tests a home-based program that uses smartphone technology to help patients prepare for stomach cancer surgery. The program is designed to improve physical fitness and overall health before surgery, which may lead to better recovery and outcomes.
This study tests a personalized, supervised exercise program that you can do from home. It aims to help improve your physical function after finishing treatment for early-stage gastroesophageal cancer.
This study is looking for people newly diagnosed with esophageal cancer or cancer at the stomach-esophagus junction who are planning to have surgery. The goal is to see if certain noninvasive tests (like scans) can help predict how the disease will progress.
This study tests whether monitoring your health at home during chemoradiation for esophageal cancer can improve care and outcomes. You'll measure things like temperature and symptoms, and share them with your care team.
This trial tests a shorter course of radiation combined with chemotherapy (FOLFOX) before surgery for esophageal or stomach-junction cancer. It aims to reduce side effects and still improve outcomes.
Hear when a new Prehabilitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.